Regeneron Executive and Leadership Team

Leonard Schleifer, the Co-Chair, President & Chief Executive Officer at Regeneron, directs the overarching corporate strategy and long-term vision for the biotechnology enterprise. Overseeing the integration of proprietary technologies into drug discovery pipelines, the Chief Executive Officer ensures alignment between scientific innovation and commercial viability. This leadership role involves managing complex stakeholder relationships and guiding the organization through rigorous regulatory landscapes. By prioritizing the development of treatments for cancer and inflammatory disorders, Leonard Schleifer maintains the company's competitive edge in the global pharmaceutical market. The Chief Executive Officer fosters a culture of scientific excellence, driving the organization toward sustainable growth while addressing unmet medical needs. Through consistent focus on high-impact research, the Chief Executive Officer secures the company's position as a leader in the biotechnology sector, ultimately delivering value to patients and shareholders alike.

Leonard Schleifer, the Board co-Chair, President & Chief Executive Officer at Regeneron, governs the strategic direction of the board while managing executive operations. Focusing on the expansion of the company's therapeutic portfolio, the Board co-Chair oversees the translation of advanced science into commercialized medicines for rare diseases. This leadership role requires constant collaboration with the scientific team to ensure that research initiatives align with the company's mission of addressing serious health conditions. By navigating the complexities of international pharmaceutical markets, Leonard Schleifer drives operational efficiency and maintains high standards of corporate governance. The Board co-Chair monitors the progress of clinical trials and ensures that the organization remains agile in the face of evolving industry challenges. Through strategic oversight of the company's resources, the Board co-Chair supports the continuous pursuit of medical breakthroughs that improve patient outcomes across diverse global populations.

George Yancopoulos, the President & Scientific Office Chief & Co-Founder at Regeneron, directs the core scientific research and development efforts that define the company's biotechnology portfolio. Overseeing the discovery of innovative medicines for cancer and inflammatory disorders, the Scientific Office Chief architects the proprietary technologies that drive the company's success. This leadership role involves guiding the research teams through the complexities of drug discovery and clinical development. By fostering a culture of scientific inquiry, George Yancopoulos ensures that the organization remains at the forefront of medical innovation. The Scientific Office Chief collaborates with the executive team to translate research breakthroughs into viable treatments for serious diseases. Through the strategic management of the research pipeline, the Scientific Office Chief supports the company's mission to improve patient lives. The leadership provided by the Scientific Office Chief is fundamental to the company's ability to maintain a robust and competitive drug development program.

Kim Brenner, the Head Operations Strategy, To Chief of Staff & Executive VP, Regulatory, Patient Safety & Quality at Regeneron, architects the operational frameworks necessary for maintaining rigorous regulatory compliance and patient safety standards. Overseeing the quality assurance processes, the Executive VP ensures that all biotechnology products meet stringent global safety requirements before reaching the market. This leadership role involves coordinating cross-functional teams to streamline regulatory submissions and optimize internal quality protocols. By integrating strategic operational planning with safety oversight, Kim Brenner mitigates risks associated with drug development and commercialization. The Executive VP works closely with the scientific and legal departments to uphold the integrity of the company's research and manufacturing processes. Through the implementation of robust quality management systems, the Executive VP supports the company's mission to deliver safe, effective treatments for serious diseases while maintaining operational excellence across all regional markets.

Erin Rohr, the Strategic HR Business Partner & To Chief of Staff & Vice President, Human Resources at Regeneron, drives the talent acquisition and organizational development strategies essential for supporting the company's scientific workforce. Overseeing the alignment of human capital with corporate objectives, the Vice President ensures that the organization attracts and retains top-tier talent capable of advancing complex biotechnology research. This leadership role involves designing comprehensive employee engagement programs and fostering a culture of innovation that supports the company's mission. By managing the strategic HR functions, Erin Rohr enables the organization to scale effectively while maintaining a focus on diversity and professional growth. The Vice President collaborates with executive leadership to address workforce challenges and optimize organizational performance. Through the development of talent management initiatives, the Vice President strengthens the company's ability to innovate and deliver life-changing treatments to patients suffering from serious diseases.

Wrechelle Nantes, the Executive Assistant To the Chief Human Resources Officer at Regeneron, facilitates the administrative and strategic operations of the human resources department. Overseeing the scheduling and communication workflows for the Chief Human Resources Officer, the Executive Assistant ensures that leadership priorities remain focused on organizational development and talent management. This leadership role involves coordinating high-level meetings and managing the flow of information between the HR department and other executive functions. By streamlining administrative processes, Wrechelle Nantes enables the Chief Human Resources Officer to dedicate more time to strategic initiatives that support the company's biotechnology mission. The Executive Assistant maintains the integrity of sensitive personnel data and supports the implementation of company-wide HR policies. Through efficient management of executive tasks, the Executive Assistant contributes to the overall operational stability of the organization, ensuring that the human resources team remains aligned with the company's broader goals.

Vicky Elsa, the 營售總監 at Regeneron, directs the commercial sales strategies and market expansion efforts for the company's innovative biotechnology products. Overseeing the distribution and market penetration of treatments for serious diseases, the 營售總監 ensures that life-changing medicines reach the patients who need them most. This leadership role involves analyzing market trends and developing targeted sales initiatives to maximize the impact of the company's therapeutic portfolio. By coordinating with regional sales teams, Vicky Elsa optimizes the commercial reach of the organization across diverse geographic markets. The 營售總監 works to build strong relationships with healthcare providers and stakeholders to ensure the successful adoption of new treatments. Through the execution of effective sales strategies, the 營售總監 supports the company's mission to address unmet medical needs and drive sustainable revenue growth. The leadership of the 營售總監 is essential for the successful commercialization of the company's scientific breakthroughs.